Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Current assets:
Cash	$ 70,029
Prepaid expenses and other assets	7,146
Total current assets	77,175
Intangible assets, net	190,637
Total assets	267,812
Current liabilities:
Accrued expenses	916,734
Short-term promissory notes and unsecured loan	204,074
Convertible promissory notes, net and accrued interest	1,459,841
Premium debt conversion derivative	441,823
Total current liabilities	3,022,472
Warrant liability	774,172
Total liabilities	3,796,644
Commitments and contingencies (Note 4)
Stockholders' deficit:
Preferred stock, $0.001 par value; 10,000,000 and 5,000,000 shares authorized as of September 30, 2017 and December 31, 2016, respectively; no shares issued or outstanding as of September 30, 2017 and December 31, 2016.
Common stock, $0.001 par value ; 100,000,000 and 45,000,000 shares authorized as of September 30, 2017 and December 31, 2016, respectively; and 7,864,994 and 5,216,565 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively.	7,865
Additional paid-in capital	162,741
Accumulated deficit	(3,699,438)
Total stockholders' deficit	(3,528,832)
Total liabilities and stockholders' deficit	$ 267,812
NeuroOne, Inc. [Member]
Current assets:
Cash		$ 522,217
Prepaid expenses and other assets		53,823
Total current assets		576,040
Intangible assets, net		180,890
Total assets		756,930
Current liabilities:
Accrued expenses		264,343
Short-term promissory notes and unsecured loan		50,000
Convertible promissory notes, net and accrued interest		225,197
Premium debt conversion derivative		137,650
Total current liabilities		677,190
Warrant liability		345,960
Total liabilities		1,023,150
Commitments and contingencies (Note 4)
Stockholders' deficit:
Preferred stock, $0.001 par value; 10,000,000 and 5,000,000 shares authorized as of September 30, 2017 and December 31, 2016, respectively; no shares issued or outstanding as of September 30, 2017 and December 31, 2016.
Common stock, $0.001 par value ; 100,000,000 and 45,000,000 shares authorized as of September 30, 2017 and December 31, 2016, respectively; and 7,864,994 and 5,216,565 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively.		31
Additional paid-in capital		119
Accumulated deficit		(266,370)
Total stockholders' deficit		(266,220)
Total liabilities and stockholders' deficit		$ 756,930

Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.